Literature DB >> 18998738

Medication overuse headache: awareness, detection and treatment.

Alan M Rapoport1.   

Abstract

Episodic migraine is a disabling painful disease that can affect the normal function of daily routine activities such as performance at work and school, and home and social relationships. In addition to the physical disability during migraine, between attacks many patients experience a condition referred to as interictal burden, which can present as pre-event worry about future attacks and can result in the anticipatory use and/or overuse of acute care medications. The overuse of medication can often lead to medication overuse headaches (MOHs) and chronic migraine. Unfortunately, patients, and even some physicians, are often unaware of this phenomenon. Therefore, it is important for knowledgeable physicians to raise awareness and to address the risks of medication overuse with their patients through effective communication. Future management of medication overuse should include detoxification and a comprehensive programme that includes the use of preventive medications such as sodium valproate (divalproex sodium) and topiramate in order to reduce dependency on acute care medication. Also, MOHs may be most effectively managed with the initiation of preventive treatment prior to detoxification, in addition to the decreased use of acute care medication. A long-term treatment plan, including behavioural therapy, migraine preventive medication and appropriate acute care therapy, may be optimal in treating patients with MOHs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18998738     DOI: 10.2165/0023210-200822120-00003

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  63 in total

1.  Invite, listen, and summarize: a patient-centered communication technique.

Authors:  Dennis Boyle; Brian Dwinnell; Frederic Platt
Journal:  Acad Med       Date:  2005-01       Impact factor: 6.893

Review 2.  Analgesic rebound headache.

Authors:  A M Rapoport
Journal:  Headache       Date:  1988-11       Impact factor: 5.887

3.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

4.  Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures.

Authors:  I Ayzenberg; M Obermann; P Nyhuis; M Gastpar; V Limmroth; H C Diener; H Kaube; Z Katsarava
Journal:  Cephalalgia       Date:  2006-09       Impact factor: 6.292

5.  Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.

Authors:  Chelsea A Meskunas; Stewart J Tepper; Alan M Rapoport; Fred D Sheftell; Marcelo E Bigal
Journal:  Headache       Date:  2006-05       Impact factor: 5.887

6.  Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.

Authors:  Julio Pascual; Benet Fité; Arturo López-Gil
Journal:  Headache       Date:  2002-02       Impact factor: 5.887

Review 7.  Strategies for diagnosing and managing medication-induced headache.

Authors:  J G Edmeads; M J Gawel; J Vickers
Journal:  Can Fam Physician       Date:  1997-07       Impact factor: 3.275

8.  Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Authors:  Stephen D Silberstein; Richard B Lipton; David W Dodick; Frederick G Freitag; Nabih Ramadan; Ninan Mathew; Jan L Brandes; Marcelo Bigal; Joel Saper; Steven Ascher; Donna M Jordan; Steven J Greenberg; Joseph Hulihan
Journal:  Headache       Date:  2007-02       Impact factor: 5.887

Review 9.  Medication-overuse headache: a worldwide problem.

Authors:  Hans-Christoph Diener; Volker Limmroth
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

10.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292

View more
  5 in total

1.  Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations.

Authors:  Randall E Weeks
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

Review 2.  The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update.

Authors:  Christina Sun-Edelstein; Alan M Rapoport; Wanakorn Rattanawong; Anan Srikiatkhachorn
Journal:  CNS Drugs       Date:  2021-05-17       Impact factor: 5.749

Review 3.  Chronic migraine plus medication overuse headache: two entities or not?

Authors:  Andrea Negro; Paolo Martelletti
Journal:  J Headache Pain       Date:  2011-09-22       Impact factor: 7.277

Review 4.  Medication-overuse headache: a widely recognized entity amidst ongoing debate.

Authors:  Nicolas Vandenbussche; Domenico Laterza; Marco Lisicki; Joseph Lloyd; Chiara Lupi; Hannes Tischler; Kati Toom; Fenne Vandervorst; Simone Quintana; Koen Paemeleire; Zaza Katsarava
Journal:  J Headache Pain       Date:  2018-07-13       Impact factor: 7.277

5.  Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study.

Authors:  Masahito Katsuki; Chinami Yamagishi; Yasuhiko Matsumori; Akihito Koh; Shin Kawamura; Kenta Kashiwagi; Tomohiro Kito; Akio Entani; Toshiko Yamamoto; Takashi Ikeda; Fuminori Yamagishi
Journal:  Neurol Sci       Date:  2022-01-19       Impact factor: 3.830

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.